厄贝沙坦联合常规治疗在改善高血压患者左室肥厚和心率变异性中作用.docVIP

厄贝沙坦联合常规治疗在改善高血压患者左室肥厚和心率变异性中作用.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
厄贝沙坦联合常规治疗在改善高血压患者左室肥厚和心率变异性中作用

厄贝沙坦联合常规治疗在改善高血压患者左室肥厚和心率变异性中作用   [摘要]目的 探讨厄贝沙坦联合常规治疗在改善高血压患者左室肥厚和心率变异性中的作用。方法 选取2015年1月~2016年12月我院收治的80例高血压患者作为研究对象,按照随机数字表法将其平均分为两组,每组各40例。对照组患者采用常规治疗,研究组患者给予厄贝沙坦联合常规治疗。比较两组患者干预前后的血压、左心室结构及心率变异性指标。结果 干预后,研究组患者的收缩压、舒张压低于对照组,差异均有统计学意义(P0.05)。研究组患者的左室结构各指标低于对照组,差异均有统计学意义(P0.05)。研究组患者的SDANN、SDNN、rMSSD、PNN50及HF指标均高于对照组,LF及LF/HF均低于对照组,差异均有统计学意义(P0.05)。结论 在高血压患者治疗中选择厄贝沙坦联合常规治疗可显著降低患者血压,改善患者左心室结构及心率变异性,对患者有积极的促进作用,值得在临床上推广使用。   [关键词]厄贝沙坦;高血压;左室肥厚;心率变异性   [中图分类号] R587.1 [文献标识码] A [文章编号] 1674-4721(2018)1(a)-0051-03   [Abstract]Objective To investigate the effect of Irbesartan combined with conventional therapy on left ventricular hypertrophy and heart rate variability in patients with hypertension.Methods 80 patients with hypertension treated in our hospital from January 2015 to December 2016 were selected as subjects and divided into two groups according to the random number table method,40 patients in each group.The patients in the control group were treated with conventional therapy,patients in the study group were given Irbesartan combined with conventional therapy.The blood pressure,left ventricular structure indexs and heart rate variability indexs were compared between the two groups before and after intervention.Results After intervention,the systolic and diastolic pressure of the study group were significantly lower than those of the control group,the differences were statistical significance (P0.05).The left ventricular correlation indexs of the study group were significantly lower than those of the control group,the differences were statistical significance (P0.05).The indexes of SDANN,SDNN,rMSSD,PNN50 and HF in the study group were significantly higher than those in the control group,and the LF and LF/HF were lower than those in the control group,the differences were statistical significance (P0.05).Conclusion In the treatment of patients with hypertension in the choice of Irbesartan combined with routine treatment can significantly reduce the blood pressur

您可能关注的文档

文档评论(0)

3471161553 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档